Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06140719 · ClinicalTrials.gov registry record
xPedite: A Study to Expedite DIPG and DMG Research
A clinical trial of Oncology and DIPG, sponsored by xCures.
- Recruiting
- Registry status
- 400
- Enrollment target
- 1
- Study location
NCT06140719: Recruiting study of Oncology and DIPG, sponsored by xCures.
NCT06140719 is a study of Oncology and DIPG that is actively recruiting participants, run by xCures. The registered enrollment target is 400 participants, below the 511-participant average among 24 other Oncology trials with a reported enrollment target (22% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06140719, a study of Oncology and DIPG, is actively recruiting participants, sponsored by xCures.
- RECRUITING
- Registry status
- 400 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will gather data from new and existing patients with patient medical records, and patient/family/caregiver reported information to establish a clear natural history of disease suitable to serve as an external, contemporary or historical control arm for future therapeutic development programs of drugs, devices, or biologic interventions in DMG or DIPG.
Primary Outcome
OS is defined as time from first dose of treatment to death due to any cause.
Study Locations (1)
California
- xCures, Inc. - Los Altos
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2023-11-01 |
| Est. Completion | 2027-01 |
What NCT06140719 shows while recruiting
NCT06140719 is an observational study that tracks outcomes without assigning an intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap, below the 511-participant average among 24 other Oncology trials with a reported enrollment target (22% lower).
The record links to 3 conditions, with Oncology appearing as the primary indexed condition, and to 0 interventions.
NCT06140719 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06140719 about?
NCT06140719 is a clinical study titled "xPedite: A Study to Expedite DIPG and DMG Research". This study will gather data from new and existing patients with patient medical records, and patient/family/caregiver reported information to establish a clear natural history of disease suitable to serve as an external, contemporary or historical control arm for future therapeutic development progr...
What is the current status of trial NCT06140719?
This trial is currently recruiting. The enrollment target is 400 participants. The study started on 2023-11-01. Estimated completion is 2027-01.
What conditions does trial NCT06140719 study?
This clinical trial studies the following conditions: Oncology, DIPG, DMG.
Who is sponsoring clinical trial NCT06140719?
This trial is sponsored by xCures, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06140719 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Oncology
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06140719's enrollment target sits among peer trials
400 5th of 24 higher than 20 of 24 other Oncology trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Oncology trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Effect of Position and Anesthetic Choice in Intraocular Pressure in Robotic GYN (Gynecologic) Oncology Patients
RECRUITING · Phase 4
-
Clinical Alternatives for Reducing Harm Using E-cigarettes
RECRUITING · NA
-
Open-Label, Dose-Escalation With Expansion to Assess the Safety, Tolerability, and PK of TRE-515 in Subjects With Solid Tumors
RECRUITING · Phase 1
-
A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors
RECRUITING · Phase 1
-
Feasibility and Acceptability of Internet-based Parent-child Interaction Therapy (I-PCIT) in Pediatric Cancer
RECRUITING · NA
-
Leading Healthy Eating and Activity Promotion Program
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01665326 · 400 participants
Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease
- NCT02108054 · 400 participants · NA
Behavioral and Functional Task Development, Implementation, and Testing
- NCT02216500 · 400 participants · NA
Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy
- NCT02250352 · 400 participants
Core Biopsies for Establishing a Breast Tumor Tissue Repository
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI